Merkel cell cancer screening: Difference between revisions
Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{VKG}} {{AAM}} | {{CMG}} ; {{AE}} {{VKG}} {{AAM}} | ||
==Overview== | ==Overview== | ||
According to the | According to the [[United states preventive services task force recommendations scheme]] ([[United states preventive services task force recommendations scheme|USPSTF]]), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for [[skin cancers]], including [[merkel cell cancer]]. | ||
==Screening== | ==Screening== | ||
According to the | According to the [[United states preventive services task force recommendations scheme]] ([[United states preventive services task force recommendations scheme|USPSTF]]), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for [[skin cancers]], including [[merkel cell cancer]]. | ||
==References== | ==References== |
Revision as of 17:58, 15 January 2019
Merkel cell cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Merkel cell cancer screening On the Web |
American Roentgen Ray Society Images of Merkel cell cancer screening |
Risk calculators and risk factors for Merkel cell cancer screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2] Ahmad Al Maradni, M.D. [3]
Overview
According to the United states preventive services task force recommendations scheme (USPSTF), there is insufficient evidence to recommend routine screening for skin cancers, including merkel cell cancer.
Screening
According to the United states preventive services task force recommendations scheme (USPSTF), there is insufficient evidence to recommend routine screening for skin cancers, including merkel cell cancer.